Trial Profile
A 5 Treatment Period Crossover Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2021
Price :
$35
*
At a glance
- Drugs Diazoxide (Primary)
- Indications Prader-Willi syndrome
- Focus Pharmacokinetics
- Sponsors Essentialis
- 14 Apr 2021 Status changed from not yet recruiting to completed as per the Soleno Therapeutics media release.
- 23 Sep 2016 New trial record